Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News

October 17, 2011 — Maquet Cardiovascular announced it has signed a three-year, dual-source contract with Premier ...

Home October 17, 2011
Home
News

October 17, 2011 — The U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) ...

Home October 17, 2011
Home
News

October 17, 2011 — The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) are ...

Home October 17, 2011
Home
News

October 7, 2011 – ValveXchange Inc., has performed successful first-in-man (FIM) surgeries demonstrating the ...

Home October 07, 2011
Home
News

October 7, 2011 — U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., released a blueprint ...

Home October 07, 2011
Home
News

Diagnostic & Interventional Cardiology (DAIC) magazine is looking for readers' opinions about what they think are the ...

Home December 23, 2011
Home
News

October 3, 2011 Maquet Cardiovascular has signed a definitive agreement to acquire Atrium Medical Corp. for $680 ...

Home October 03, 2011
Home
News

October 3, 2011 —The American Society of Echocardiography (ASE) has published guidelines for new applications for ...

Home October 03, 2011
Home
News

October 3, 2011 — JenaValve Technology GmbH, a German company specializing in the development of transcatheter heart ...

Home October 03, 2011
Home
News

October 3, 2011 – Cardiac Dimensions Inc. announced it received European CE mark approval for a newly enhanced version ...

Home October 03, 2011
Home
News

October 3, 2011 – Boston Scientific has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foR Heart F ...

Home October 03, 2011
Home
News

September 27, 2011 – Health 2.0 announced the launch of the Novartis CardioEngagement Challenge, asking multi ...

Home September 27, 2011
Home
News

September 27, 2011 — Occlutech announced its CEO, Tor Peters, has obtained a favorable ruling from the district court in ...

Home September 27, 2011
Home
News

September 27, 2011 — A team of physicians, engineers and materials scientists at Children's Hospital Boston and the ...

Home September 27, 2011
Home
News

September 27, 2011 — Last week’s inclusion of critical congenital heart disease (CCHD) in the standard list of ...

Home September 27, 2011
Home
Subscribe Now